[go: up one dir, main page]

AU2925789A - Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection - Google Patents

Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection

Info

Publication number
AU2925789A
AU2925789A AU29257/89A AU2925789A AU2925789A AU 2925789 A AU2925789 A AU 2925789A AU 29257/89 A AU29257/89 A AU 29257/89A AU 2925789 A AU2925789 A AU 2925789A AU 2925789 A AU2925789 A AU 2925789A
Authority
AU
Australia
Prior art keywords
cells
hiv infection
adoptive immunotherapy
lymphokine activation
lymphokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29257/89A
Inventor
James C. Sharp
Abdul Jabear Sultan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BROWNING S CLINICAL PATHOLOGY
Original Assignee
BROWNING S CLINICAL PATHOLOGY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878729410A external-priority patent/GB8729410D0/en
Priority claimed from GB888817082A external-priority patent/GB8817082D0/en
Priority claimed from GB888823897A external-priority patent/GB8823897D0/en
Priority claimed from GB888823895A external-priority patent/GB8823895D0/en
Priority claimed from GB888823896A external-priority patent/GB8823896D0/en
Application filed by BROWNING S CLINICAL PATHOLOGY filed Critical BROWNING S CLINICAL PATHOLOGY
Publication of AU2925789A publication Critical patent/AU2925789A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/50—Cellular immunotherapy characterised by the use of allogeneic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/24—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/59—Lectins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU29257/89A 1987-12-17 1988-12-19 Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection Abandoned AU2925789A (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB878729410A GB8729410D0 (en) 1987-12-17 1987-12-17 Method for production of lymphokine activated killer(lak)cells & lak cells so produced
GB8729410 1987-12-17
GB8817082 1988-07-18
GB888817082A GB8817082D0 (en) 1988-07-18 1988-07-18 Method for production of lymphokine activated killer(lak)cells so produced & their use
GB888823897A GB8823897D0 (en) 1988-10-12 1988-10-12 Process for stimulating & activating lymphocytes
GB8823896 1988-10-12
GB8823895 1988-10-12
GB888823895A GB8823895D0 (en) 1988-10-12 1988-10-12 Lymphokine activation of lymphocytes
GB888823896A GB8823896D0 (en) 1988-10-12 1988-10-12 Improvements relating to lymphokine activated cells
GB8823897 1988-10-12

Publications (1)

Publication Number Publication Date
AU2925789A true AU2925789A (en) 1989-07-19

Family

ID=27516781

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29257/89A Abandoned AU2925789A (en) 1987-12-17 1988-12-19 Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection

Country Status (2)

Country Link
AU (1) AU2925789A (en)
WO (1) WO1989005657A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE147633T1 (en) * 1988-10-27 1997-02-15 Univ Minnesota IMMUNE AID FROM LIPOSOMES CONTAINING LYMPHOKINE IL -2
US5725855A (en) * 1991-04-05 1998-03-10 The United States Of America As Represented By The Department Of Health And Human Services Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
WO1992017567A1 (en) * 1991-04-05 1992-10-15 Regents Of The University Of Minnesota Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
IE922233A1 (en) * 1991-07-10 1993-01-13 Augusto C Ochoa Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity
DE69227042T3 (en) * 1991-12-31 2006-07-27 Zymogenetics, Inc., Seattle METHOD AND COMPOSITIONS FOR REDUCING BLOOD LOSS
DE4228389C2 (en) * 1992-08-26 1994-07-21 Kuebler Gmbh Dr Collection and cultivation of transformed cells
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US7541184B2 (en) 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
KR20040048379A (en) * 2001-06-01 2004-06-09 싸이트 테라피스 인코포레이티드 T cell induced tissue repair and regeneration
US20050226857A1 (en) * 2001-06-01 2005-10-13 Xcyte Therapies, Inc. T cell therapy for the treatment of cachexia and chronic diseases
JPWO2005051927A1 (en) * 2003-11-26 2007-12-06 株式会社クレハ Method for culturing CD4-positive T cells by stimulation culture of HIV-1-infected peripheral blood mononuclear cells, and HIV-1 growth inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2106935B (en) * 1981-10-01 1985-01-30 Otsuka Pharma Co Ltd Cancer cell-combatting lymphocytes process for the production thereof and anticancer agents containing said lymphocytes
ES8800981A1 (en) * 1985-06-28 1987-12-01 Univ Minnesota A PROCEDURE FOR TREATING EFFECT CELLS THAT HAVE SURFACE RECEPTORS FOR THE FC REGION OF AN ANTIBODY
US4690915A (en) * 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans
DE3782736T2 (en) * 1986-04-28 1993-06-09 Endotronics Inc BREEDING PROCESS FOR LEUKOCYTEN.
AU7873187A (en) * 1986-08-08 1988-02-24 University Of Minnesota Method of culturing leukocytes
EP0257962A3 (en) * 1986-08-29 1989-05-24 Becton, Dickinson and Company Method for treatment of peripheral blood to improve lymphokine activated killer immunotherapy
EP0260714B1 (en) * 1986-09-19 1994-06-29 Oncogen Limited Partnership The use of activated t-lymphocytes for preparing a pharmaceutical composition for the treatment of AIDS
AU1363088A (en) * 1987-03-11 1988-10-10 Children's Hospital Incorporated, The Method for the generation of antigen-specific t cell lines and therapeutic use thereof

Also Published As

Publication number Publication date
WO1989005657A1 (en) 1989-06-29

Similar Documents

Publication Publication Date Title
AU589732B2 (en) Process for the preparation of 2-oxo-1,3-dioxolanes
AU607944B2 (en) Cell growth rate determination
AU7469787A (en) Process for the genetic modification of yeast
AU585385B2 (en) Process for the preparation of 2-oxo-1,3-dioxolanes
AU2828989A (en) Long-life membrane electrode for non-ionic species
AU1435588A (en) Blood centrifugation cell
AU1514888A (en) Improved membrane configurations
AU7211887A (en) Thienopyrimidine-2,4-dione derivatives
AU2925789A (en) Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection
AU590699B2 (en) Radial arm saw
AU1365588A (en) Thin film membrane, enzyme reactors
AU1665088A (en) New compounds, processes for their preparation and uses thereof
AU590847B2 (en) Conveying, supporting and shaping glass sheets
AU2458988A (en) The preparation, by genetic manipulation, of anticoagulative protein pp4
AU7646087A (en) Covalent membranes
AU1574188A (en) T-cell membrane protein
AU2348588A (en) Catalyst composition for polymerizing alpha olefins
AU1004588A (en) Solution ibuprofen complexes, compositions and processes for preparing same
AU3447589A (en) Process for manufacture of plates, especially for construction use
AU1569988A (en) New aminophenylethylamine derivatives, processes for their preparation and their use as yield promoters
AU8306987A (en) Novel carbamoyloxylabdanes, intermediates and a process for the preparation thereof and their use as medicaments
AU2180988A (en) Sulfonic acid-glycidamide reaction product, use as catalyst
AU6940087A (en) Covalent membranes
AU8178987A (en) Orientable support
CA1265131C (en) Derivatives of erythromycylamine